Showing results (291-300 of 297) with videos related to
Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 297 results.
Journal of the National Cancer Institute|December 11, 2014
Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studiesMatthew P Goetz, James X Sun, Vera J Suman, et al.Clinical Pharmacology and Therapeutics|November 19, 2020
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 PneumoniaGarth W Strohbehn, Brian L Heiss, Sherin J Rouhani, et al.European Journal of Cancer (Oxford, England : 1990)|September 16, 2019
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumoursRobin L Jones, Mark J Ratain, Peter J O'Dwyer, et al.Breast Cancer Research and Treatment|May 8, 2020
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015Peter H O'Donnell, Vassily Trubetskoy, Ashley Nurhussein-Patterson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L Hertz, Kouros Owzar, Sherrie Lessans, et al.Journal of the National Cancer Institute|October 15, 2010
Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translationAndrew N Freedman, Leah B Sansbury, William D Figg, et al.The New England Journal of Medicine|October 29, 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancerEunice L Kwak, Yung-Jue Bang, D Ross Camidge, et al.Pageof 30